2023 Form 5500 filing — Adare Pharmaceuticals, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20250218154221NAL0003098657001) for Adare Pharmaceuticals, Inc. 401(K) Plan, reported by Adare Pharmaceuticals, Inc. under EIN 31-0988732 and plan number 003. It reports 324 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20250218154221NAL0003098657001
Filing year
2023
Form type
2
Plan sponsor
Adare Pharmaceuticals, Inc.
EIN
31-0988732
Plan number
003
Location
Lawrenceville, NJ
Participants
324
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$57,752,901
Total liabilities (EOY)
$5,003
Net assets (EOY)
$57,747,898
Employer contributions
$1,942,784
Participant contributions
$3,989,335
Total income / additions
$15,383,368
Benefits paid
$3,594,774
Administrative expenses
$107,326
Total expenses
$3,702,100
Net increase / (decrease)
$11,681,268
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Fidelity Investments InstitutionalRECORDKEEPER$40,493$0
Nfp Retirement IncADVISOR/INVESTMENT ADV$37,500not reported in the loaded dataset
Katz, Sapper & MillerACCOUNTANT/AUDITOR$29,333not reported in the loaded dataset

Related Form 5500 pages